Phantom-Validated Reference Values of Myocardial Mapping and Extracellular Volume at 3T in Healthy Koreans
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Myocardial T1 and T2 relaxation times are affected by technical factors such as cardiovascular magnetic resonance platform/vendor. We aimed to validate T1 and T2 mapping sequences using a phantom; establish reference T1, T2, and extracellular volume (ECV) measurements using two sequences at 3T in normal Koreans; and compare the protocols and evaluate the differences from previously reported measurements. Materials and Methods: Eleven healthy subjects underwent cardiac magnetic resonance imaging (MRI) using 3T MRI equipment (Verio, Siemens, Erlangen, Germany). We did phantom validation before volunteer scanning: T1 mapping with modified look locker inversion recovery (MOLLI) with 5(3)3 and 4(1)3(1)2 sequences, and T2 mapping with gradient echo (GRE) and TrueFISP sequences. We did T1 and T2 mappings on the volunteers with the same sequences. ECV was also calculated with both sequences after gadolinium enhancement. Results: The phantom study showed no significant differences from the gold standard T1 and T2 values in either sequence. Pre-contrast T1 relaxation times of the 4(1)3(1)2 protocol was 1142.27 ± 36.64 ms and of the 5(3)3 was 1266.03 ± 32.86 ms on the volunteer study. T2 relaxation times of GRE were 40.09 ± 2.45 ms and T2 relaxation times of TrueFISP were 38.20 ± 1.64 ms in each. ECV calculation was 24.42% ± 2.41% and 26.11% ± 2.39% in the 4(1)3(1)2 and 5(3)3 protocols, respectively, and showed no differences at any segment or slice between the sequences. We also calculated ECV from the pre-enhancement T1 relaxation time of MOLLI 5(3)3 and the postenhancement T1 relaxation time of MOLLI 4(1)3(1)2, with no significant differences between the combinations. Conclusion: Using phantom-validated sequences, we reported the normal myocardial T1, T2, and ECV reference values of healthy Koreans at 3T. There were no statistically significant differences between the sequences, although it has limited statistical value due to the small number of subjects studied. ECV showed no significant differences between calculations based on various pre- and post-mapping combinations.
Abstract
Purpose: Myocardial T1 and T2 relaxation times are affected by technical factors such as cardiovascular magnetic resonance platform/vendor. We aimed to validate T1 and T2 mapping sequences using a phantom; establish reference T1, T2, and extracellular volume (ECV) measurements using two sequences at 3T in normal Koreans; and compare the protocols and evaluate the differences from previously reported measurements. Materials and Methods: Eleven healthy subjects underwent cardiac magnetic resonance imaging (MRI) using 3T MRI equipment (Verio, Siemens, Erlangen, Germany). We did phantom validation before volunteer scanning: T1 mapping with modified look locker inversion recovery (MOLLI) with 5(3)3 and 4(1)3(1)2 sequences, and T2 mapping with gradient echo (GRE) and TrueFISP sequences. We did T1 and T2 mappings on the volunteers with the same sequences. ECV was also calculated with both sequences after gadolinium enhancement. Results: The phantom study showed no significant differences from the gold standard T1 and T2 values in either sequence. Pre-contrast T1 relaxation times of the 4(1)3(1)2 protocol was 1142.27 ± 36.64 ms and of the 5(3)3 was 1266.03 ± 32.86 ms on the volunteer study. T2 relaxation times of GRE were 40.09 ± 2.45 ms and T2 relaxation times of TrueFISP were 38.20 ± 1.64 ms in each. ECV calculation was 24.42% ± 2.41% and 26.11% ± 2.39% in the 4(1)3(1)2 and 5(3)3 protocols, respectively, and showed no differences at any segment or slice between the sequences. We also calculated ECV from the pre-enhancement T1 relaxation time of MOLLI 5(3)3 and the postenhancement T1 relaxation time of MOLLI 4(1)3(1)2, with no significant differences between the combinations. Conclusion: Using phantom-validated sequences, we reported the normal myocardial T1, T2, and ECV reference values of healthy Koreans at 3T. There were no statistically significant differences between the sequences, although it has limited statistical value due to the small number of subjects studied. ECV showed no significant differences between calculations based on various pre- and post-mapping combinations.
참고문헌 (17)
- Marijianowski MM, "Dilated cardiomyopathy is associated with an increase in the type I", type III collagen ratio : a quantitative assessment, 1995, pp.25, 1263~1272
- Kellman P, "Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method", J Cardiovasc Magn Reson, 14, pp.63~ (2012)
- Moon JC, "Myocardial T1mapping and extracellular volume quantification : a Society for Cardiovascular Magnetic Resonance(SCMR)and CMR Working Group of the European Society of Cardiology consensus statement", J Cardiovasc Magn Reson, 15, pp.92~ (2013)
- Cerqueira MD, "Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association", Circulation, 105, pp.539~542 (2002)
- Stanisz GJ, "T1, T2 relaxation and magnetization transfer in tissue at 3T", Magn Reson Med, 54, pp.507~512 (2005)
- Dall'Armellina E, "Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction", J Cardiovasc Magn Reson, 14, pp.15~ (2012)
- Piechnik SK, "Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9heartbeat breathhold", J Cardiovasc Magn Reson, 12, pp.69~ (2010)
- von Knobelsdorff-Brenkenhoff F, "Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications", J Cardiovasc Magn Reson, 15, pp.53~ (2013)
- Dabir D, "Reference values for healthy human myocardium using a T1 mapping methodology : results from the International T1 Multicenter cardiovascular magnetic resonance study", J Cardiovasc Magn Reson, 16, pp.69~ (2014)
- Rogers T, "Standardization of T1 measurements with MOLLI in differentiation between health and disease--the ConSept study", J Cardiovasc Magn Reson, 15, pp.78~ (2013)
- Dong Y, "Age and gender impact the measurement of myocardial interstitial fibrosis in a healthy adult chinese population : a cardiac magnetic resonance study", Front Physiol, 9, pp.140~ (2018)
- Puntmann VO, "Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy", JACC Cardiovasc Imaging, 6, pp.475~484 (2013)
- Markl M, "Myocardial T2-mapping and velocity mapping : changes in regional left ventricular structure and function after heart transplantation", Magn Reson Med, 70, pp.517~526 (2013)
- Schelbert EB, "Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans : slow infusion versus bolus", J Cardiovasc Magn Reson, 13, pp.16~ (2011)
- Piechnik SK, "Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI", J Cardiovasc Magn Reson, 15, pp.13~ (2013)
- Liu CY, "Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping : MESA(Multi-Ethnic Study of Atherosclerosis)", J Am Coll Cardiol, 62, pp.1280~1287 (2013)
- Olivetti G, "Gender differences and aging : effects on the human heart", J Am Coll Cardiol, 26, pp.1068~1079 (1995)